Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Nov 8, 2017	J	847,787	$0.00	D	2,164,898	I	See footnote
Common Stock	Nov 8, 2017	J	8,478	$0.00	A	8,478	D
Common Stock^F5	Nov 8, 2017	J	116,243	$0.00	D	296,837	I	See footnote
Common Stock^F7	Nov 8, 2017	J	35,970	$0.00	D	91,851	I	See footnote
Common Stock	Nov 8, 2017	J	360	$0.00	A	8,838	D
Common Stock	Nov 8, 2017	J	8,838	$0.00	D	0	D
Common Stock^F11	Nov 8, 2017	J	1,033	$0.00	A	3,721	I	See footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

F1Maveron Equity Partners III, L.P. ("Maveron Equity") made pro rata distributions for no consideration of 847,787 shares of common stock of the issuer to its partners on November 8, 2017.
F10Shares acquired by Maveron LLC in connection with the distribution of such shares to the partners of Maveron Associates and to the members of Maveron GP.
F11Shares are owned directly by Maveron LLC. Maveron LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein. In addition, Dan Levitan, who is a Director of the issuer, and the managing member of Maveron LLC and may be deemed to share voting and investment power over the shares held of record by Maveron LLC. Mr. Levitan disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F2Shares are owned directly by Maveron Equity. Maveron General Partner III LLC ("Maveron GP"), which is the general partner of Maveron Equity, has sole voting and investment power over the securities held by Maveron Equity. Maveron GP disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein. In addition, Dan Levitan, who is a Director of the issuer, and certain other individuals are managing members of Maveron GP and may be deemed to share voting and investment power over the shares held of record by Maveron Equity. Each of such individuals disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F3Shares acquired by Maveron GP in connection with the distribution of such shares to the partners of Maveron Equity.
F4MEP Associates III, L.P. ("Maveron Associates") made pro rata distributions for no consideration of 116,243 shares of common stock of the issuer to its partners on November 8, 2017.
F5Shares are owned directly by Maveron Associates. Maveron GP, which is the general partner of Maveron Associates, has sole voting and investment power over the securities held by Maveron Associates. Maveron GP disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein. In addition, Dan Levitan, who is a Director of the issuer, and certain other individuals are managing members of Maveron GP and may be deemed to share voting and investment power over the shares held of record by Maveron Associates. Each of such individuals disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F6Maveron III Entrepreneurs Fund, L.P. ("Maveron Entrepreneurs") made pro rata distributions for no consideration of 35,970 shares of common stock of the issuer to its partners on November 8, 2017.
F7Shares are owned directly by Maveron Entrepreneurs. Maveron GP, which is the general partner of Maveron Entrepreneurs, has sole voting and investment power over the securities held by Maveron Entrepreneurs. Maveron GP disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein. In addition, Dan Levitan, who is a Director of the issuer, and certain other individuals are managing members of Maveron GP and may be deemed to share voting and investment power over the shares held of record by Maveron Entrepreneurs. Each of such individuals disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F8Shares acquired by Maveron GP in connection with the distribution of such shares to the partners of Maveron Entrepreneurs.
F9Maveron GP made pro rata distributions for no consideration of 8,838 shares of common stock of the issuer to its members on November 8, 2017.

Remarks

Each reporting person disclaims the existence of a "group" and disclaims beneficial ownership of any securities except to the extent of such reporting persons' pecuniary interest in such securities.